Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€68.02

€68.02

-0.670%
-0.46
-0.670%
-

-

 
23.12.25 / Tradegate WKN: A2PDXE / Name: Alcon / Stock / ? /
Your prediction

Alcon AG Stock

Alcon AG shows a slight decrease today, losing -€0.460 (-0.670%) compared to yesterday.

Pros and Cons of Alcon AG in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval
Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval


Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY® Vitreoretinal Cataract System (VCS) has received Health Canada approval. This

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)


Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire LumiThera, Inc., a leader in light-based innovations for